Industry Focus

A drop dead, massively big, upside opportunity exists for this pre-clinical stage biotech star. Motley Fool analyst Michael Douglass and contributor Todd Campbell discuss this and much more.

Direct download: 150401_IF_Healthcare.mp3
Category:Podcast -- posted at: 5:17pm EST